Articles On Avita Medical (ASX:AVH)

Are you looking for some small cap ASX shares to add to your watchlist? Then I would highly recommend you take a look at the ones listed below. Here’s why I think they have a lot of potential and are worth keeping a close eye on: Avita Me...

The S&P/ASX 200 Index (ASX: XJO) dropped by around 2% today, falling by 1.7% to 6,051 points. Here are some of the highlights from the ASX today: Widespread selling Overnight there was a selloff in international markets, seemingly on w...

ASX shares have a long track record of innovation, and of punching above their weight. For example, Avita Therapeutics Inc (ASX: AVH) is pioneering spray on skin for treating burns. However, Afterpay Ltd (ASX: APT), with no technological a...

The Avita Therapeutics Inc (ASX: AVH) share price has started the week in a positive fashion. The regenerative medicine company’s shares are up over 3% to $7.43 in afternoon trade. Why is the Avita share price charging higher? The catalyst...

After 30 years of investing I have made my fair share of mistakes, but I have also had some great investments. A good ASX share in my view can be 1 of 2 things. A solid value investment, where I have been able to find an undervalued good c...

Shares in Avita Thereapeutics Inc (ASX: AVH) surged nearly 15% higher following the company’s release of its annual report for FY20. The Avita share price soared to $7.10 at the opening bell before being sold down to a more modest gain of...

ShareCafeOvernight: Fly Me To The Moon World Overnight SPI Overnight (Sep) 6095.00 + 15.00 0.25% S&P ASX 200 6116.40 – 45.00 – 0.73% S&P500 3478.73 + 35.11 1.02% Nasdaq Comp 11665.06 + 198.59 1.73% DJIA 28331.92 + 83.48...

World Overnight SPI Overnight (Sep) 6095.00 + 15.00 0.25% S&P ASX 200 6116.40 – 45.00 – 0.73% S&P500 3478.73 + 35.11 1.02% Nasdaq Comp 11665.06 + 198.59 1.73% DJIA 28331.92 + 83.48 0.30% S&P500 VIX 23.27 + 1.24 5.6...

The ASX200 rose 0.5% in July led by materials, technology and consumer staples; the August reporting season may find companies hesitant to provide guidance amid an uncertain outlook -The ASX200 tottered to a monthly gain of 0.5% in July-The...

Like all financial markets, ASX shares produce winners and losers. Some companies soar to spectacular market capitalisations as their product or service takes off. Others see share prices deteriorate as markets and demand shift. When inv...

It seems investors in these two ASX medical shares have taken the opportunity to lock in recent gains, sending prices down significantly in July. The Avita Therapeutics Inc (ASX: AVH) share price fell more than 30% in July as sales faltere...

In July, the S&P/ASX 200 (ASX: XJO) saw a halt to previous gains. Rising coronavirus infections in Victoria tempered investor appetite with the index ending the month 29.9 points down. On that note, let’s take a look at the worst perfo...

Despite a disappointing finish to the month, the S&P/ASX 200 Index (ASX: XJO) recorded a 0.5% gain to end it at 5927.8 points. Unfortunately, not all shares on the index were climbing higher with the market in July. Here’s why these we...

An additional news report on the recommendation, valuation, forecast and opinion changes for ASX-listed equities. In addition to The Australian Broker Call Report, which is published and updated daily (Mon-Fri), FNArena has now added The Au...

The medical device industry includes any device which can diagnose, prevent, or treat a disease or other condition. Examples range from bandages and syringes to pacemakers and prostheses. These technologies save and improve lives by detect...

The Avita Therapeutics Inc (ASX: AVH) (NASDAQ: RCEL) share price was trading 10.53% lower today following an investor update to do with its BARDA partnership. For context, the broader Australian share market or S&P/ASX 200 (ASX: XJO) wa...

The S&P/ASX 200 Index (ASX: XJO) fell by 0.6% today to 5,919 points. The alarming COVID-19 spread continues in Melbourne with Victoria reporting 288 new cases today. However, two new infections in NSW that seemingly came from a Sydney...

In late morning trade the S&P/ASX 200 Index (ASX: XJO) is on course to end the week in the red. At the time of writing the benchmark index is down 0.25% to 5,940.4 points. Four shares that have fallen more than most today are listed be...

The Avita (ASX: AVH) share price is down more than 1% after providing an update for FY20. What is Avita? Avita is a regenerative medicine company. It aims to address unmet medical needs in burns, chronic wounds and aesthetics indications. I...

The AVITA Therapeutics Inc (ASX: AVH) share price will be on watch on Friday after the release of its fourth quarter update. How did AVITA perform in the fourth quarter? For the fourth quarter of FY 2020, the regenerative medicine company...

Australia is an amazingly innovative country – from the medical application of penicillin, the invention of WiFi, right through to the cochlear implant or bionic ear. Heck, Australia was even the birthing ground for what would become Googl...

In early afternoon trade the S&P/ASX 200 Index (ASX: XJO) looks set to start the new financial year on a positive note. At the time of writing the benchmark index is up 0.9% to 5,949.1 points. Four shares that have failed to follow the...

After redomiciling to the United States yesterday, the Avita Therapeutics Inc (ASX: AVH) share price is up 8.4% today. Avita Medical’s ordinary shares were transferred to Avita Therapeutics, based out of the US state of Delaware, via a sc...

The S&P/ASX 200 Index (ASX: XJO) rose by 0.1% to 5,943 points today. It was retail that dominated the headlines. According to the stats produced by the Australian Bureau of Statistics (ABS), Australian retail sales surged 16.3% in May...

Allied health group Advent Health is preparing to join the ranks of the ASX by way of a reverse takeover next month with a plan to improve efficiencies and boost profitability of its founding practices. The move entails shell company Mill...

The journey of each individual medical treatment from idea to market requires the involvement of multiple parties big and small. The general consensus seems to be that it takes a big player to get a drug to market, which more often than not...

The bulls are back following a massive almost 40 per cent upwards run over the last 50 days, but bearish investors are holding on to a range of theories as to why the worst is yet to come. Since the March 23 low, stocks have run harder than...

In the past fortnight there were over 30 directors trades of $100,000 or more among ASX small cap directors. The list included multiple groups of directors. Five directors from water treatment stock Phoslock (ASX:PET) put in $1.3m between t...

Morningstar believes there are some real bargain stocks to be found on the ASX. It has just released its monthly ‘Best Stock Ideas’ report highlighting companies trading at discounts to its assessed fair values. Three of them were small cap...

Due to the favourable tailwinds that it is experiencing, I believe the healthcare sector is a great place to invest with a long term view. But with so many options for investors to choose from, which ones should you be buying? Below are th...

02 Jun 2020 - AVITA Medical (ASX:AVH) has submitted an Investigational Device Exemption (IDE) supplement with the US Food and Drug Administration (FDA) for a clinical trial to inve…

Around 12 months ago, we noted that Avita Medical (AVH) – which provides a novel approach to skin regeneration – was a business worth keeping tabs on.  Although its share price has felt the effects of the COVID-19 market sell-off, our posit...

Last year was a solid year for many ASX stocks and 2020 was also looking pretty good until COVID-19 struck the markets in late February. Earlier this week Reuben Adams recapped which of last year’s top mining and exploration companies have...

Want to know which stocks the fund managers have been putting their money in (and out) of? We’ve been keeping track so you don’t have to. Trading Places is Stockhead’s recap of substantial holder movements among ASX small caps in the last f...

The S&P/ASX 200 Index (ASX: XJO) ended the day up 0.35% to 5,422 points. The ASX 200 was down over 1% earlier in the day. China and Australia’s dispute continues to grow. The Asian superpower reminded Australia how important it is to t...

The S&P/ASX 200 Index (ASX: XJO) was back on form in April and had its best month in decades. Over the period the benchmark index recorded a gain of 8.8%. Not all shares were able to follow the market higher last month. Here’s why thes...

“Your Stock Request” is a weekly video where we analyse share price charts for stocks on the Australian market (ASX) as requested by you! Email us at [email protected] with your stock request. Limit of one per person, no guarantee o...

Avita Medical Ltd (ASX: AVH) shares are down 2.17% in morning trade, despite the ASX healthcare company reporting strong third quarter results today.  Avita Medical reported total product sales of $5.9 million during the March quarter, up...

The S&P/ASX 200 Index (ASX: XJO) is on course to record a very strong gain on Wednesday. In late morning trade the benchmark index is up 1.2% to 5,376.4 points. Four shares that have failed to follow the market higher today are listed...

With the Avita Medical Ltd (ASX:AVH) share price sitting at 45 cents at time of writing, let’s take a quick look at this stock that lit up the ASX prior to the onset of the coronavirus. Avita recently announced a plan to relocate from Austr...

In late morning trade the S&P/ASX 200 Index (ASX: XJO) has followed the lead of U.S. markets and dropped lower. At the time of writing the benchmark index is down 1.3% to 5,157.9 points. Four shares that are not letting that hold them...

Noxopharm (ASX:NOX) is the latest biotech to announce it will test its drug against COVID-19. So how exactly does an anti-prostate cancer drug work for COVID-19? Noxopharm says it is all about one signalling pathway — the STING (Stimulator...

Regenerative medicine company AVITA Medical (ASX:AVH) has announced its intention to redomicile from Australia to the US.

With the S&P/ASX 200 down as much as 130 points on Wednesday morning and a large percentage of Monday’s substantial rebound now lost, it may pay to scour the market for pockets of value. While also succumbing to the downturn in the broa...

With the S&P/ASX 200 down as much as 130 points on Wednesday morning and a large percentage of Monday’s substantial rebound now lost, it may pay to scour the market for pockets of value. While also succumbing to the downturn in the broa...

Alcidion’s (ASX:ALC) market cap may suggest it’s still a small cap, but it has come a long way from its founding and reverse IPO in 2016. The company is now larger than all 11 other ASX medtechs it listed in its investor presentation as com...

The healthcare sector has been one of the top-performing ASX industry sectors during the coronavirus crisis. This is only likely to continue over the next 6 months due to a high and continuing demand for a range of healthcare products and...

ASX shares are trading at deep discounts from previous highs thanks to the coronavirus pandemic. This gives investors the chance to swoop in on some bargains. So, let’s take a look at 5 ASX shares to buy across the technology and healthca...

The Ramsay Health Care Limited (ASX: RHC) share price is back on form on Thursday. On Wednesday Ramsay’s shares fell heavily after the government announced that it would soon stop elective surgeries. But in afternoon trade the private hosp...

Yesterday I highlighted a number of factors that could be seen as justification for investing in more speculative stocks in the current environment. Though seemingly counter-intuitive given the broader flight from equities to safe havens su...